Total Payments
$17,200
2024 Payments
$3,575
Companies
5
Transactions
8

Payment Breakdown by Category

Consulting$16,875 (98.1%)
Food & Beverage$325.31 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $16,875 3 98.1%
Food and Beverage $325.31 5 1.9%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $13,395 2 $0 (2022)
Eli Lilly and Company $1,875 1 $0 (2024)
Averitas Pharma Inc. $1,700 1 $0 (2024)
Teva Pharmaceuticals USA, Inc. $188.89 2 $0 (2017)
Avanir Pharmaceuticals, Inc. $41.03 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,575 2 Eli Lilly and Company ($1,875)
2022 $13,395 2 ABBVIE INC. ($13,395)
2018 $21.19 1 Avanir Pharmaceuticals, Inc. ($21.19)
2017 $208.73 3 Teva Pharmaceuticals USA, Inc. ($188.89)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/23/2024 Averitas Pharma Inc. Consulting Fee Cash or cash equivalent $1,700.00 General
11/25/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $1,875.00 General
06/09/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $95.39 General
Category: NEUROSCIENCE
04/13/2022 ABBVIE INC. QULIPTA (Drug) Consulting Fee Cash or cash equivalent $13,300.00 General
Category: NEUROSCIENCE
04/18/2018 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $21.19 General
Category: Migraine
12/05/2017 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $19.84 General
Category: Migraine
09/08/2017 Teva Pharmaceuticals USA, Inc. TEV-48125 (Biological) Food and Beverage In-kind items and services $127.63 General
Category: Central Nervous System
09/08/2017 Teva Pharmaceuticals USA, Inc. TEV-48125 (Biological) Food and Beverage In-kind items and services $61.26 General
Category: Central Nervous System

About William Renthal

William Renthal is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1598064883.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Renthal has received a total of $17,200 in payments from pharmaceutical and medical device companies, with $3,575 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($16,875).

Practice Information

Products in Payments

  • QULIPTA (Drug) $13,300
  • TEV-48125 (Biological) $188.89
  • UBRELVY (Drug) $95.39
  • ONZETRA Xsail (Drug) $41.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Dallas